This inventor holds 1 USPTO granted patent. Top assignee: Union Therapeutics A/s. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Morten Lind Jensen: Innovator in Pharmaceutical Treatments
Introduction
Morten Lind Jensen is a notable inventor based in Hellerup, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diseases through innovative dosage regimens.
Latest Patents
Morten holds a patent for a dosage regimen involving orismilast. This patent outlines the use of orismilast for treating diseases or disorders that can be ameliorated by inhibiting PDE in a subject. Additionally, it specifies the administration of orismilast for the treatment of pruritus associated with atopic dermatitis. He has 1 patent to his name.
Career Highlights
Morten is currently associated with Union Therapeutics A/S, where he continues to work on advancing pharmaceutical treatments. His expertise in the field has positioned him as a valuable asset in the development of innovative therapies.
Collaborations
Morten has collaborated with notable colleagues, including Morten Otto Alexander Sommer and Jakob Felding, contributing to various projects within the pharmaceutical industry.
Conclusion
Morten Lind Jensen's work exemplifies the impact of innovation in healthcare, particularly through his patent on orismilast. His contributions continue to influence the treatment of significant medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile